| 000 | 01857 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517213044.0 | ||
| 264 | 0 | _c20191114 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1365-2222 | ||
| 024 | 7 |
_a10.1111/cea.13160 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCaillaud, D | |
| 245 | 0 | 0 |
_aShort-term effect of outdoor mould spore exposure on prescribed allergy medication sales in Central France. _h[electronic resource] |
| 260 |
_bClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _c07 2018 |
||
| 300 |
_a837-845 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAllergens _ximmunology |
| 650 | 0 | 4 |
_aAnti-Allergic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDrug Prescriptions _xstatistics & numerical data |
| 650 | 0 | 4 |
_aEnvironmental Exposure _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 |
_aHistamine Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypersensitivity _xdrug therapy |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPollen _xadverse effects |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSpores, Fungal _ximmunology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCheriaux, M | |
| 700 | 1 | _aMartin, S | |
| 700 | 1 | _aSégala, C | |
| 700 | 1 | _aDupuy, N | |
| 700 | 1 | _aEvrard, B | |
| 700 | 1 | _aThibaudon, M | |
| 773 | 0 |
_tClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _gvol. 48 _gno. 7 _gp. 837-845 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cea.13160 _zAvailable from publisher's website |
| 999 |
_c28329709 _d28329709 |
||